Reports
Sale
Global Immunoglobulin Market Size, Growth, Share, Forecast: By Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Others; By Route of Administration; By Clinical Trial; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
Key Industry Players in the Global Immunoglobulin Market
The report presents a detailed analysis of the following key players in the global immunoglobulin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Biotest AG
- Octapharma AG
- Baxter International Inc.
- China Biologics Products Inc.
- Grifols SA
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Immunoglobulin Market Report Snapshots
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Immunoglobulin Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunoglobulin Historical Market (2017-2023)
8.3 Global Immunoglobulin Market Forecast (2024-2032)
8.4 Global Immunoglobulin Market by Application
8.4.1 Hypogammaglobulinemia
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 CIPD
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Immunodeficiency Diseases
8.4.3.1 Historical Trend (2017-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Congenital AIDS
8.4.4.1 Historical Trend (2017-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Chronic Lymphocytic Leukaemia
8.4.5.1 Historical Trend (2017-2023)
8.4.5.2 Forecast Trend (2024-2032)
8.4.6 Myasthenia Gravis
8.4.6.1 Historical Trend (2017-2023)
8.4.6.2 Forecast Trend (2024-2032)
8.4.7 Multifocal Motor Neuropathy
8.4.7.1 Historical Trend (2017-2023)
8.4.7.2 Forecast Trend (2024-2032)
8.4.8 ITP
8.4.8.1 Historical Trend (2017-2023)
8.4.8.2 Forecast Trend (2024-2032)
8.4.9 Kawasaki Disease
8.4.9.1 Historical Trend (2017-2023)
8.4.9.2 Forecast Trend (2024-2032)
8.4.10 Guillain-Barre Syndrome
8.4.10.1 Historical Trend (2017-2023)
8.4.10.2 Forecast Trend (2024-2032)
8.5 Global Immunoglobulin Market by Route of Administration
8.5.1 Intravenous
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Subcutaneous
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Immunoglobulin Market by Clinical Trial
8.6.1 IgG
8.6.1.1 Historical Trend (2017-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 IgA
8.6.2.1 Historical Trend (2017-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 IgM
8.6.3.1 Historical Trend (2017-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 IgE
8.6.4.1 Historical Trend (2017-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 IgD
8.6.5.1 Historical Trend (2017-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.7 Global Immunoglobulin Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2017-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2017-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2017-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2017-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2017-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Immunoglobulin Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Immunoglobulin Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Immunoglobulin Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Immunoglobulin Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Immunoglobulin Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Biotest AG
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Octapharma AG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Baxter International Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 China Biologics Products Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Grifols SA
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
17 Key Trends and Developments in the Market
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Material
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investment
List of Key Figures and Tables
1. Global Immunoglobulin Market: Key Industry Highlights, 2017 and 2032
2. Global Immunoglobulin Historical Market: Breakup by Application (USD Billion), 2017-2023
3. Global Immunoglobulin Market Forecast: Breakup by Application (USD Billion), 2024-2032
4. Global Immunoglobulin Historical Market: Breakup by Route of Administration (USD Billion), 2017-2023
5. Global Immunoglobulin Market Forecast: Breakup by Route of Administration (USD Billion), 2024-2032
6. Global Immunoglobulin Historical Market: Breakup by Clinical Trial (USD Billion), 2017-2023
7. Global Immunoglobulin Market Forecast: Breakup by Clinical Trial (USD Billion), 2024-2032
8. Global Immunoglobulin Historical Market: Breakup by Region (USD Billion), 2017-2023
9. Global Immunoglobulin Market Forecast: Breakup by Region (USD Billion), 2024-2032
10. North America Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2017-2023
11. North America Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Europe Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2017-2023
13. Europe Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Asia Pacific Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2017-2023
15. Asia Pacific Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Latin America Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2017-2023
17. Latin America Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Middle East and Africa Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2017-2023
19. Middle East and Africa Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Global Immunoglobulin Market Structure
Key Questions Answered in the Report
The market attained a value of approximately USD 14.62 billion in 2023.
The market is projected to grow at a CAGR of 7.1% in the forecast period of 2024-2032.
The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach about USD 27.17 billion by 2032.
The market is being driven by the rising prevalence of immunodeficiency conditions, and the emergence of enhanced purification techniques.
The key trends of the market include the applications of immunoglobulin in treatment of various neurological disorders and improvements in healthcare infrastructure.
The major regional markets for immunoglobulin are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The various applications of immunoglobulin are hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukaemia, myasthenia gravis, multifocal motor neuropathy, ITP, kawasaki disease, and guillain-barre syndrome.
The major routes of administration of immunoglobulin are intravenous and subcutaneous.
The different clinical trials in the market include IgG, IgA, IgM, IgE, and IgD.
The key players in the global immunoglobulin market are Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., and Grifols SA.
Analyst Review
The global immunoglobulin market attained a value of about USD 14.62 billion in 2023, driven by the presence of prominent industry players. Aided by improvements in the R&D sector for treatment of various diseases, the market is expected to grow at a CAGR of 7.1% in the forecast period of 2024-2032 to reach nearly USD 27.17 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of applications, the industry can be segmented into hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukaemia, myasthenia gravis, multifocal motor neuropathy, ITP, kawasaki disease and, guillain-barre syndrome. On the basis of mode of administration, the market can be divided into intravenous and subcutaneous. Based on clinical trial, the market segmentations include IgG, IgA, IgM, IgE, and IgD. The major regional markets for Immunoglobulin are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., and Grifols SA.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER